Dixon Hubard Feinour Brown Incva Lowers stake in CVS Health Corp (CVS)

CVS Health Corp (CVS) : Dixon Hubard Feinour Brown Incva reduced its stake in CVS Health Corp by 2.19% during the most recent quarter end. The investment management company now holds a total of 74,947 shares of CVS Health Corp which is valued at $7,769,755 after selling 1,681 shares in CVS Health Corp , the firm said in a disclosure report filed with the SEC on May 9, 2016.CVS Health Corp makes up approximately 2.55% of Dixon Hubard Feinour Brown Incva’s portfolio.

Other Hedge Funds, Including , Sippican Capital Advisors boosted its stake in CVS in the latest quarter, The investment management firm added 853 additional shares and now holds a total of 3,500 shares of CVS Health Corp which is valued at $362,845. CVS Health Corp makes up approx 0.46% of Sippican Capital Advisors’s portfolio.Montag A Associates Inc boosted its stake in CVS in the latest quarter, The investment management firm added 41,910 additional shares and now holds a total of 105,080 shares of CVS Health Corp which is valued at $11,017,638. CVS Health Corp makes up approx 1.54% of Montag A Associates Inc’s portfolio.Boston Financial Mangement Inc reduced its stake in CVS by selling 2,974 shares or 2.23% in the most recent quarter. The Hedge Fund company now holds 130,253 shares of CVS which is valued at $13,657,027. CVS Health Corp makes up approx 2.04% of Boston Financial Mangement Inc’s portfolio.Parkwood reduced its stake in CVS by selling 3,236 shares or 52.62% in the most recent quarter. The Hedge Fund company now holds 2,914 shares of CVS which is valued at $305,533. CVS Health Corp makes up approx 0.05% of Parkwood’s portfolio.Greenleaf Trust reduced its stake in CVS by selling 695 shares or 18.67% in the most recent quarter. The Hedge Fund company now holds 3,028 shares of CVS which is valued at $304,314. CVS Health Corp makes up approx 0.01% of Greenleaf Trust’s portfolio.

CVS Health Corp closed down -1.18 points or -1.13% at $103.67 with 34,13,616 shares getting traded on Friday. Post opening the session at $104.38, the shares hit an intraday low of $103.47 and an intraday high of $104.85 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, CVS Health Corp reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on May 3, 2016. Analyst had a consensus of $1.16. The company had revenue of $43215.00 million for the quarter, compared to analysts expectations of $43000.77 million. The company’s revenue was up 18.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS.

Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Mizuho on May 4, 2016 to “Buy”, Firm has raised the Price Target to $ 117 from a previous price target of $104 .Company shares were Reiterated by RBC Capital Mkts on May 4, 2016 to “Outperform”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .Company shares were Reiterated by Barclays on Mar 10, 2016 to “Overweight”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .

CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.

Leave a Reply

CVS Health Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on CVS Health Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.